Montreal Heart Institute
Polygenic Risk Scores Predict Heart Disease in French-Canadian Cohort
The two genome-wide scores to predict coronary artery disease risk, which were developed using UK Biobank data, were also valid in French-Canadians.
Although analyses for other drugs in the class have failed to confirm the influence of genotype, Dalcor is moving forward with its clinical trial, expecting some results by the end of this year.
The genetics center has launched an NGS panel for inherited cardiovascular diseases and plans to develop pharmacogenomics and cholesterol metabolism panels.
Illumina Partners With Four Institutions to Genotype Biobank Samples
Vanderbilt University, the University of Colorado at Denver, Partners HealthCare, and the Montreal Heart Institute will use Illumina technology to analyze their biobank samples.
MHI, AstraZeneca Team on Genetic Analysis of CVD, Diabetes Markers
The partners are using genomic data to improve understanding of cardiovascular disease and diabetes and identify markers linked to drug response.